6-156778889-CGGAGGAGGAGGAGGA-CGGAGGAGGAGGAGGAGGAGGAGGA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.1226_1234dupGAGGAGGAG​(p.Gly409_Gly411dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000839 in 143,056 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00079 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.98

Publications

0 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778889-C-CGGAGGAGGA is Benign according to our data. Variant chr6-156778889-C-CGGAGGAGGA is described in ClinVar as [Likely_benign]. Clinvar id is 589786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000839 (120/143056) while in subpopulation AMR AF = 0.00296 (43/14550). AF 95% confidence interval is 0.00225. There are 0 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High AC in GnomAd4 at 120 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1226_1234dupGAGGAGGAG p.Gly409_Gly411dup disruptive_inframe_insertion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1226_1234dupGAGGAGGAG p.Gly409_Gly411dup disruptive_inframe_insertion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.000839
AC:
120
AN:
142982
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000515
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00296
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000803
Gnomad OTH
AF:
0.00254
GnomAD2 exomes
AF:
0.000180
AC:
6
AN:
33354
AF XY:
0.000101
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00144
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000948
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000789
AC:
965
AN:
1223528
Hom.:
1
Cov.:
35
AF XY:
0.000727
AC XY:
436
AN XY:
599372
show subpopulations
African (AFR)
AF:
0.000125
AC:
3
AN:
23958
American (AMR)
AF:
0.00268
AC:
39
AN:
14562
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18616
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27064
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40134
Middle Eastern (MID)
AF:
0.000454
AC:
2
AN:
4406
European-Non Finnish (NFE)
AF:
0.000878
AC:
871
AN:
992574
Other (OTH)
AF:
0.00101
AC:
50
AN:
49424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000839
AC:
120
AN:
143056
Hom.:
0
Cov.:
29
AF XY:
0.000845
AC XY:
59
AN XY:
69794
show subpopulations
African (AFR)
AF:
0.000514
AC:
20
AN:
38934
American (AMR)
AF:
0.00296
AC:
43
AN:
14550
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3376
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4448
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
254
European-Non Finnish (NFE)
AF:
0.000804
AC:
52
AN:
64716
Other (OTH)
AF:
0.00252
AC:
5
AN:
1982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
1

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B: BS1 -

Mar 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Sep 21, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ARID1B-related disorder Benign:1
Oct 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.0
Mutation Taster
=69/31
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747790383; hg19: chr6-157100023; COSMIC: COSV106363496; COSMIC: COSV106363496; API